Status:
COMPLETED
Pancreatic Stent for Distal Pancreatectomy
Lead Sponsor:
Ruijin Hospital
Conditions:
Distal Pancreatectomy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to compare outcomes of patients undergoing distal pancreatectomy with or without pancreatic stent
Eligibility Criteria
Inclusion
- Patients undergoing distal pancreatectomy
- Signed the informed consents
Exclusion
- Recurrence patients
- pre-operative anti-cancer treatment
- patients with contraindication(hepatic/ respiratory/ renal dysfunction, etc )
- AJCC stage IV
- pre operative oddi'ssphincter incision
- operation non radical
- pancreatic stent not at place
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03314337
Start Date
November 1 2017
End Date
December 31 2022
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025